Stocksigma LogoStocksigma Logo

Asston Pharmaceuticals Approves Key Appointments, Auditor Change, and Remuneration Hikes at AGM

Asston Pharmaceuticals shareholders approved key resolutions at the AGM on 29th Sep'26. Members adopted the audited standalone financial statements for the

Asston Pharmaceuticals Approves Key Appointments, Auditor Change, and Remuneration Hikes at AGM

Asston Pharmaceuticals Ltd 路 Change in Management 路 01 Oct 2026, 7:33 pm

Asston Pharmaceuticals Approves Key Appointments, Auditor Change, and Remuneration Hikes at AGM Asston Pharmaceuticals shareholders approved key resolutions at the AGM on 29th Sep'26. Members adopted the audited standalone financial statements for the fiscal ended 31st Mar'26 and approved the re-appointment of Managing Director Ashish Narayan Sakalkar, retiring by rotation. The company appointed M/s Panchal S K & Associates as Statutory Auditors. Additionally, shareholders approved remuneration increases for MD Ashish Narayan Sakalkar, Whole-time Director & CEO Saili Jayaram More, and Non-Executive Director Sachin Chandrakant Badakh.

Original exchange filing (PDF)

More announcements from Asston Pharmaceuticals Ltd

All Asston Pharmaceuticals Ltd announcements